← All stocks

BSX vs DXCM

Boston Scientific Corporation Common Stock vs DexCom Inc. Common Stock. Side-by-side ACCE scores, valuation, profitability, and growth.

ACCE scores
BSX
DXCM
Composite score
Out of 100
57
76
Growth
56
76
Value
75
39
Quality
79
92
Momentum
17
97
Valuation
BSX
DXCM
Price
43.34
89.35
Market cap
62.81B
33.72B
Trailing P/E
17.55
35.32
Forward P/E
12.84
28.74
EV / EBITDA
13.29
21.27
Dividend yield
0.0%
0.0%
Profitability
BSX
DXCM
ROE
15.3%
38.5%
Net margin
17.5%
20.1%
Debt / equity
0.47
0.46
Free cash flow
3.66B
1.08B
Growth
BSX
DXCM
Revenue growth (YoY)
7.5%
13.1%
Earnings growth (YoY)
15.1%
43.6%
Analyst target
61.76
94.48
See full analysis